FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Silvana Del Vecchio

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Rosa Fonti; Michele Larobina; Fabrizio Pane; Marco Salvatore; Lucio Catalano; Serena De Luca; Silvana Del Vecchio; Rossella Fabbricini; Leonardo Pace
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
Antonella Zannetti; Francesca Iommelli; Marco Salvatore; antonio speranza; Silvana Del Vecchio
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Silvana Del Vecchio; Antonella Zannetti; Rosa Fonti; F Iommelli; L M Pizzuti; A Lettieri; Marco Salvatore
PET/CT in cancer research: from preclinical to clinical applications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Silvana Del Vecchio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rosa Fonti; Michele Larobina; Fabrizio Pane; Marco Salvatore; Lucio Catalano; Serena De Luca; Silvana Del Vecchio; Rossella Fabbricini; Leonardo Pace
Metabolic tumor volume assessed by 18F-FDG PET/CT for the prediction of outcome in patients with multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(12):1829-35.
2012: Antonella Zannetti; Francesca Iommelli; Marco Salvatore; antonio speranza; Silvana Del Vecchio
3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(3):443-50.
2010: Silvana Del Vecchio; Antonella Zannetti; Rosa Fonti; F Iommelli; L M Pizzuti; A Lettieri; Marco Salvatore
PET/CT in cancer research: from preclinical to clinical applications.
Contrast media & molecular imaging 2010;5(4):190-200.
2010: Emilio Bombardieri; Valentina Ambrosini; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; Silvana Del Vecchio; Lorenzo Maffioli; Luc Mortelmans; Wim Oyen; Giovanna Pepe; Arturo Chiti
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
European journal of nuclear medicine and molecular imaging 2010;37(7):1441-8.
2010: Silvana Del Vecchio; Antonella Zannetti; F Iommelli; A Lettieri; A Brunetti; Marco Salvatore
Molecular imaging of tumor microenvironment: challenges and perspectives.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2010;54(3):249-58.
2009: Rossella Fabbricini; Lucio Catalano; Leonardo Pace; Silvana Del Vecchio; Rosa Fonti; Marco Salvatore; Bruno Rotoli
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(8):1385; author reply 1385.
2009: Stefania De Luca; Annarita Del Gatto; Menotti Ruvo; Maria Rosaria Panico; Antonella Zannetti; Silvana Del Vecchio; Marco Salvatore; Carlo Pedone; Michele Saviano; Laura Zaccaro
A new and selective radiolabeled alphavbeta3 peptide antagonist as tracer in tumor diagnosis.
Advances in experimental medicine and biology 2009;611():439-40.
2008: Melania Pulcrano; Luigi Camera; Loredana Pagano; Silvana Del Vecchio; Diego Ferone; L Bodei; A Murgia; Leonardo Pace; Giovanni Storto; G Paganelli; Annamaria Colao; Marco Salvatore; Gaetano Lombardi; Bernadette Biondi
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease.
Journal of endocrinological investigation 2008;31(4):352-9.
2008: Rosa Fonti; Barbara Salvatore; Mario Quarantelli; Cesare Sirignano; Sabrina Segreto; Fara Petruzziello; Lucio Catalano; Raffaele Liuzzi; Bruno Rotoli; Silvana Del Vecchio; Leonardo Pace; Marco Salvatore
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(2):195-200.
2007: Silvana Del Vecchio; Antonella Zannetti; Rosa Fonti; Leonardo Pace; Marco Salvatore
Nuclear imaging in cancer theranostics.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2007;51(2):152-63.
2007: Lucio Catalano; Silvana Del Vecchio; Fara Petruzziello; Rosa Fonti; Barbara Salvatore; Carmen Martorelli; Catello Califano; Giuseppe Caparrotti; Sabrina Segreto; Leonardo Pace; Bruno Rotoli
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis.
Annals of hematology 2007;86(6):415-23.
2006: Annarita Del Gatto; Laura Zaccaro; Paolo Grieco; Ettore Novellino; Antonella Zannetti; Silvana Del Vecchio; Francesca Iommelli; Marco Salvatore; Carlo Pedone; Michele Saviano
Novel and selective alpha(v)beta3 receptor peptide antagonist: design, synthesis, and biological behavior.
Journal of medicinal chemistry 2006;49(11):3416-20.
2006: Leonardo Pace; Marco Salvatore; Silvana Del Vecchio
Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(3):555.
2005: Antonella Zannetti; Silvana Del Vecchio; Alessandra Romanelli; Stefania Scala; Michele Saviano; Gaetano Cali'; Maria Patrizia Stoppelli; Carlo Pedone; Marco Salvatore
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells.
Biochemical pharmacology 2005;70(9):1277-87.
2005: Leonardo Pace; Lucio Catalano; Silvana Del Vecchio; Amalia De Renzo; Rosa Fonti; Barbara Salvatore; Claudia Andretta; Carmine di Nuzzo; Bruno Rotoli; Marco Salvatore
Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2005;49(3):281-5.
2005: Lucio Catalano; Claudia Andretta; Leonardo Pace; Silvana Del Vecchio; Barbara Salvatore; Gaetano De Rosa; Maria Teresa Buonanno; Gaetano Paone; Bruno Rotoli
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma.
Hematology (Amsterdam, Netherlands) 2005;10(4):335-8.
2005: Libuse Tauchmanovà; Matilde Pensabene; I Capuano; Ilaria Spagnoletti; Pio Zeppa; Silvana Del Vecchio; M Mainenti; G De Rosa; Annamaria Colao; Alma Contegiacomo
Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR.
Journal of endocrinological investigation 2005;28(4):371-8.
2005: Leonardo Pace; Silvana Del Vecchio; Marco Salvatore
Technetium 99m sestamibi in multiple myeloma.
Radiology 2005;234(1):312-3; author reply 313.
2004: Silvana Del Vecchio; Marco Salvatore
99mTc-MIBI in the evaluation of breast cancer biology.
European journal of nuclear medicine and molecular imaging 2004;31 Suppl 1():S88-96.
2004: Rosa Fonti; Silvana Del Vecchio; Antonella Zannetti; Amalia De Renzo; Lucio Catalano; Leonardo Pace; Bruno Rotoli; Marco Salvatore
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma.
Cancer biotherapy & radiopharmaceuticals 2004;19(2):165-70.
2004: Luigi Aloj; Antonella Zannetti; Corradina Caracó; Silvana Del Vecchio; Marco Salvatore
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines.
European journal of nuclear medicine and molecular imaging 2004;31(4):521-7.
2004: Luigi Aloj; Corradina Caracò; Mariarosaria Panico; Antonella Zannetti; Silvana Del Vecchio; Diego Tesauro; Stefania De Luca; Claudio Arra; Carlo Pedone; Giancarlo Morelli; Marco Salvatore
In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(3):485-94.
2004: Luigi Aloj; Mariarosaria Panico; Corradina Caraco; Silvana Del Vecchio; Claudio Arra; Andrea Affuso; Antonella Accardo; Rosalba Mansi; Diego Tesauro; Stefania De Luca; Carlo Pedone; Roberta Visentin; Ulderico Mazzi; Giancarlo Morelli; Marco Salvatore
In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging.
Cancer biotherapy & radiopharmaceuticals 2004;19(1):93-8.
2003: Leonardo Pace; Marco Salvatore; Silvana Del Vecchio
A new role for nuclear medicine in multiple myeloma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(8):1369; author reply 1369.
2003: Silvana Del Vecchio; Antonella Zannetti; Luigi Aloj; Corradina Caracò; Andrea Ciarmiello; Marco Salvatore
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma.
European journal of nuclear medicine and molecular imaging 2003;30(6):879-87.
2003: Silvana Del Vecchio; Antonella Zannetti; Luigi Aloj; Marco Salvatore
MIBI as prognostic factor in breast cancer.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 2003;47(1):46-50.
2003: Luigi Camera; Silvana Del Vecchio; Mario Quarantelli; F Ibello; Teresa Pellegrino; Marco Salvatore
Radiolabeled somatostatin analogs in the diagnosis and staging of neuroendocrine tumors.
Journal of endocrinological investigation 2003;26(8 Suppl):60-2.
2002: Silvana Del Vecchio; Antonella Zannetti; Andrea Ciarmiello; Luigi Aloj; Corradina Caracò; Rosa Fonti; Gerardo Botti; Giuseppe D'Aiuto; Marco Salvatore
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients.
European journal of nuclear medicine and molecular imaging 2002;29(6):809-14.
2002: Luigi Aloj; Mariarosaria Panico; Corradina Caracó; Antonella Zannetti; Silvana Del Vecchio; Carmine di Nuzzo; Claudio Arra; Giancarlo Morelli; Diego Tesauro; Stefania De Luca; Carlo Pedone; Marco Salvatore
Radiolabeling approaches for cholecystokinin B receptor imaging.
Biopolymers 2002;66(6):370-80.
2001: Leonardo Pace; Lucio Catalano; Silvana Del Vecchio; F Di Gennaro; Amalia De Renzo; G Sica; Catello Califano; N Tedesco; G Borrelli; Bruno Rotoli; Marco Salvatore
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
European journal of nuclear medicine 2001;28(3):304-12.
2001: Rosa Fonti; Silvana Del Vecchio; Antonella Zannetti; Amalia De Renzo; F Di Gennaro; Lucio Catalano; Catello Califano; Leonardo Pace; Bruno Rotoli; Marco Salvatore
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
European journal of nuclear medicine 2001;28(2):214-20.
2001: Massimo Imbriaco; Silvana Del Vecchio; Albina Riccardi; Leonardo Pace; F Di Salle; F Di Gennaro; Marco Salvatore; Antonio Sodano
Scintimammography with 99mTc-MIBI versus dynamic MRI for non-invasive characterization of breast masses.
European journal of nuclear medicine 2001;28(1):56-63.
2000: Silvana Del Vecchio; Andrea Ciarmiello; Marco Salvatore
Scintigraphic detection of multidrug resistance in cancer.
Cancer biotherapy & radiopharmaceuticals 2000;15(4):327-37.
2000: Antonella Zannetti; Silvana Del Vecchio; Maria Vincenza Carriero; Rosa Fonti; Paola Franco; Gerardo Botti; Giuseppe D'Aiuto; Maria Patrizia Stoppelli; Marco Salvatore
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.
Cancer research 2000;60(6):1546-51.
1999: Maria Vincenza Carriero; Silvana Del Vecchio; M Capozzoli; Paola Franco; L Fontana; Antonella Zannetti; Gerardo Botti; Giuseppe D'Aiuto; Marco Salvatore; Maria Patrizia Stoppelli
Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.
Cancer research 1999;59(20):5307-14.
1999: Silvana Del Vecchio; Andrea Ciarmiello; Marco Salvatore
Clinical imaging of multidrug resistance in cancer.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(2):125-31.
1999: Lucio Catalano; Leonardo Pace; Catello Califano; AM Pinto; Amalia De Renzo; F Di Gennaro; Silvana Del Vecchio; Rosa Fonti; Marco Salvatore; Bruno Rotoli
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
Haematologica 1999;84(2):119-24.
1999: F Di Gennaro; Lucio Catalano; Leonardo Pace; Amalia De Renzo; AM Pinto; Silvana Del Vecchio; Bruno Rotoli; Marco Salvatore
Tc-99m sestamibi scintigraphy in multiple myeloma.
Clinical nuclear medicine 1999;24(2):115-6.
1999: G Esposito; Alfonso Tempesta; MG Galati; M de Bellis; Giovanni B Rossi; MI Potena; Pietro Marone; Bruno Daniele; Silvana Del Vecchio
Mucosal expression of carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with gastritis and gastric cancer.
Cancer detection and prevention 1999;23(2):116-22.
1998: Leonardo Pace; Lucio Catalano; A Pinto; Amalia De Renzo; F Di Gennaro; Catello Califano; Silvana Del Vecchio; Bruno Rotoli; Marco Salvatore
Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
European journal of nuclear medicine 1998;25(7):714-20.
1998: Marco Salvatore; Silvana Del Vecchio
Dynamic imaging: scintimammography.
European journal of radiology 1998;27 Suppl 2():S259-64.
1998: Andrea Ciarmiello; Silvana Del Vecchio; P Silvestro; MI Potena; Maria Vincenza Carriero; R Thomas; Gerardo Botti; Giuseppe D'Aiuto; Marco Salvatore
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1677-83.
1998: Silvana Del Vecchio; Andrea Ciarmiello; M Salvatore
Wash-out kinetics of 99mTc-MIBI and the scintigraphic determination of Pgp expression: reply.
European journal of nuclear medicine 1998;25(2):192.
1997: Silvana Del Vecchio; Andrea Ciarmiello; Leonardo Pace; MI Potena; Maria Vincenza Carriero; Ciro Mainolfi; R Thomas; Giuseppe D'Aiuto; T Tsuruo; Marco Salvatore
Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1348-51.
1997: Maria Vincenza Carriero; Silvana Del Vecchio; Paola Franco; MI Potena; F Chiaradonna; Gerardo Botti; Maria Patrizia Stoppelli; Marco Salvatore
Vitronectin binding to urokinase receptor in human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1299-308.
1996: P Y Li; Silvana Del Vecchio; R Fonti; Maria Vincenza Carriero; MI Potena; G Botti; Silvia Miotti; Secondo Lastoria; S Menard; MI Colnaghi; Marco Salvatore
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(4):665-72.
1994: Maria Vincenza Carriero; Paola Franco; Silvana Del Vecchio; O Massa; Gerardo Botti; Giuseppe D'Aiuto; Maria Patrizia Stoppelli; Marco Salvatore
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.
Cancer research 1994;54(20):5445-54.
1994: Silvana Del Vecchio; Maria Patrizia Stoppelli; Maria Vincenza Carriero; R Fonti; O Massa; P Y Li; Gerardo Botti; M Cerra; Giuseppe D'Aiuto; G Esposito
In vitro receptor imaging for characterization of human solid tumors.
Nuclear medicine and biology 1994;21(5):771-4.
1993: Silvana Del Vecchio; Maria Patrizia Stoppelli; Maria Vincenza Carriero; R Fonti; O Massa; P Y Li; Gerardo Botti; M Cerra; Giuseppe D'Aiuto; G Esposito
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.
Cancer research 1993;53(13):3198-206.
1991: L Camera; Silvana Del Vecchio; A Petrillo; G Esposito; Giuseppe Frasci; Rosario Vincenzo Iaffaioli; A R Bianco; Marco Salvatore
Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma.
European journal of nuclear medicine 1991;18(4):269-73.
1991: Silvana Del Vecchio; Luigi Mansi; A Petrillo; L Camera; M Sofia; A Marra; L Carratù; Marco Salvatore
Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer.
European journal of nuclear medicine 1991;18(2):129-32.
1991: Silvana Del Vecchio; L Camera; A Petrillo; G Esposito; Giuseppe Frasci; Rosario Vincenzo Iaffaioli; A R Bianco; Marco Salvatore
Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(1):85-7.
1989: Marco Salvatore; Secondo Lastoria; Silvana Del Vecchio; Luigi Mansi
Detection of colon cancer with radiolabelled monoclonal antibodies.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(2):103-4.